santa cruz biotechnology, inc.
TSC-22 D2 (C-20) Antibody: sc-55406
| Datasheet
goat polyclonal IgG, 200µg/ml epitope mapping at the C-terminus of TSC-22 D2 of human origin recommended for detection of TSC-22 D2 of mouse, rat and human origin by WB, IF and ELISA; also reactive with additional species, including equine, canine, bovine and porcine blocking peptide, sc-55406 P
Ordering Information
Recommended Support Products:
(click button of application of choice)
Species
Gene Name
Gene ID
Chromosome Location
Isoform (mRNA) Accession #
Protein Accession #
OMIM™ Number
Human
TSC22D2
9819
3q25.1
NM_014779
O75157
n/a
Mouse
Tsc22d2
72033
3 D
NP_001074698
N/A
TSC-22 D2 Background Information Transforming growth factor-beta-stimulated clone-22 (TSC-22) acts as a transcriptional regulator to modulate cell growth and differentiation, as well as cell death. TSC-22 contains a leucine zipper domain as well as a nuclear export signal, resulting in cytoplasmic localization in living cells. However, concomitant with the induction of apoptosis, TSC-22 translocates from the cytoplasm to the nucleus and shows transcriptional regulatory activity. TSC-22 acts as a major downstream component in both the TGF-beta pathway and the PPAR© signaling pathway. The association of these two pathways with tumor suppression, and the significant downregulation of TSC-22 mRNA in various cancer types, implies an antiproliferative role for TSC-22. TSC-22 D2 (TSC22 domain family protein 2), also known as TILZ4, is a 780 amino acid protein that is related to TSC-22 and is involved in adaptation of renal cells to hypertonicity, suggesting a possible role in signal transduction. Three isoforms exist due to alternative splicing events.